MedChunk
Medically reviewed

What Are the Side Effects of Asthma Biologics?

Learn about the common and serious side effects of asthma biologics, including injection reactions, headaches, allergic reactions, and medication-specific risks.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 10 min read

Asthma biologics can cause side effects such as injection-site pain, redness, headaches, and mild infections. Some medicines also carry a rare risk of serious allergic reactions. The exact risks depend on which biologic is used, and many people tolerate these treatments well.

Which side effects are common with asthma biologics?

Asthma biologics are targeted medicines used as an add-on treatment for certain people with severe asthma. Although they act on specific parts of the immune system, they can still cause unwanted reactions.

According to the American Academy of Allergy, Asthma and Immunology (AAAAI), different biologics target different pathways involved in airway inflammation. Their side-effect profiles therefore overlap in some areas but are not identical.

Commonly reported side effects include:

  • Injection-site reactions: Pain, redness, swelling, itching, bruising, or warmth where the medicine is injected.
  • Headaches: Some people experience headaches after receiving treatment.
  • Cold-like symptoms: A runny nose, sore throat, or other upper respiratory symptoms may occur with certain medicines.
  • Joint or muscle discomfort: Some biologics have been associated with joint pain or general body aches.
  • Fatigue: Tiredness has been reported with some treatments.
  • Skin reactions: Itching, rashes, or hives may occur in some people.

These effects are not experienced by everyone. Some are also reported in people receiving placebo treatment during clinical trials, so not every symptom occurring during treatment is necessarily caused by the biologic.

How do side effects differ between asthma biologics?

There are several types of biologic medicines for asthma. Each targets a different immune pathway, so the possible side effects depend partly on the medicine prescribed.

Omalizumab (Xolair)

Omalizumab is used for certain people with allergic asthma. Commonly reported effects include headaches, joint pain, dizziness, and reactions where the injection is given.

One important safety concern is anaphylaxis, a sudden, potentially life-threatening allergic reaction. The US National Library of Medicine's DailyMed prescribing information for Xolair carries a boxed warning about this risk.

Anaphylaxis can occur after the first dose or even after someone has received treatment for a long time. This is why healthcare professionals take precautions when starting omalizumab and monitor patients appropriately after administration.

Mepolizumab (Nucala)

Mepolizumab targets interleukin-5 (IL-5), a protein involved in the activity of eosinophils, a type of white blood cell associated with certain forms of asthma.

Possible side effects include:

  • Headache
  • Injection-site reactions
  • Back pain
  • Fatigue
  • Cold-like symptoms

Herpes zoster, commonly known as shingles, is also a safety consideration reported with this treatment. People who develop a painful blistering rash should contact their healthcare professional for assessment.

Benralizumab (Fasenra)

Benralizumab targets the IL-5 receptor and reduces eosinophils. Possible side effects include headaches, sore throat, and hypersensitivity reactions.

According to the DailyMed prescribing information for Fasenra, allergic reactions can include hives, rash, swelling beneath the skin, and anaphylaxis. These reactions may occur within hours of treatment, although delayed reactions have also been reported.

Dupilumab (Dupixent)

Dupilumab blocks certain immune signals involved in type 2 inflammation. It is used for selected patients with asthma and may also be prescribed for other inflammatory conditions.

Possible side effects include:

  • Injection-site reactions
  • Eye redness or inflammation
  • Conjunctivitis (inflammation of the clear covering over the eye)
  • Joint pain
  • Cold-like symptoms

Eye symptoms deserve attention if they persist, become painful, or affect vision. Dupilumab can also be associated with changes in eosinophil levels in some patients, requiring clinical assessment when relevant.

Tezepelumab (Tezspire)

Tezepelumab blocks thymic stromal lymphopoietin (TSLP), a protein involved in inflammation in the airways.

Reported side effects include sore throat, joint pain, and back pain. Injection-site reactions and allergic reactions are also possible. The specific risks should be discussed using the prescribing information for the product being considered.

Can asthma biologics cause serious allergic reactions?

Yes. Although uncommon, some asthma biologics can cause hypersensitivity reactions, which range from mild skin reactions to severe allergic reactions.

Anaphylaxis requires immediate medical attention. Warning signs may include:

  • Difficulty breathing or sudden worsening of breathing
  • Swelling of the lips, tongue, face, or throat
  • Widespread hives or sudden itching
  • Dizziness, fainting, or a sudden drop in blood pressure
  • Sudden tightness in the throat or difficulty swallowing

If these symptoms occur after a biologic injection or infusion, seek emergency medical assistance immediately. Do not wait to see whether they improve on their own.

Omalizumab and reslizumab have particularly important anaphylaxis warnings. However, serious allergic reactions are possible with other biologics too. A previous uneventful dose does not completely eliminate the possibility of a later reaction.

Can biologics increase the risk of infections?

Infections are another consideration when discussing the safety of asthma biologics. Some patients report upper respiratory infections, such as colds, sore throats, or sinus symptoms, during treatment.

However, the infection risk is not the same for every medicine. These drugs target specific immune pathways rather than suppressing the entire immune system in the same way as some broader immunosuppressive treatments.

For example, shingles has been reported as a safety concern with mepolizumab. People should discuss their vaccination history and individual infection risks with their healthcare professional rather than assuming that every biologic has the same effects on immunity.

Are there any long-term side effects of asthma biologics?

Available clinical studies and follow-up data provide information about the safety of these medicines, but the amount of long-term evidence differs between individual treatments.

Research continues to examine possible concerns, including serious allergic reactions, infections, changes in immune-cell levels, and other uncommon adverse events.

A 2025 review published in PubMed Central, covering adverse effects of biologics used for asthma, discusses hypersensitivity, infections, malignancy, cardiovascular events, eosinophilia, vaccination, and pregnancy-related safety considerations.

Importantly, discussing a possible risk does not mean that a biologic has been proven to cause that outcome. For example, available evidence does not establish that asthma biologics as a group cause cancer. The safety of each medicine needs to be considered separately.

Who may need extra precautions before starting treatment?

Before prescribing a biologic, a healthcare professional reviews the patient's medical history, previous medication reactions, current medicines, and relevant health conditions.

Additional discussion may be important for people who:

  • Have previously experienced a serious allergic reaction to a biologic or one of its ingredients.
  • Have a history of parasitic infections or a current suspected parasitic infection, where relevant to the medicine.
  • Have previously experienced shingles or have concerns about vaccination.
  • Are pregnant, planning pregnancy, or breastfeeding.
  • Are taking long-term oral corticosteroids or other medicines that may need careful adjustment.

These factors do not automatically prevent someone from receiving biologic treatment. They help healthcare professionals assess potential risks and decide whether additional precautions or monitoring are appropriate.

When should you contact a healthcare professional?

Some mild injection-site reactions can settle without specific treatment. However, new or persistent symptoms should be discussed with the prescribing team, particularly if they interfere with daily activities.

Contact your healthcare professional if you experience:

  • A persistent or worsening rash.
  • Repeated infections or symptoms that do not improve.
  • Ongoing eye redness, pain, or vision changes while receiving dupilumab.
  • New joint pain or unexplained persistent fatigue.
  • Worsening asthma symptoms despite receiving biologic treatment.

Breathing difficulty accompanied by facial or throat swelling, fainting, or other signs of anaphylaxis requires emergency care.

How can you reduce the risk of side effects?

Although side effects cannot always be prevented, a few practical steps can help support safer treatment:

  • Follow the prescribed schedule: Receive injections or infusions at the recommended intervals.
  • Report previous allergic reactions: Tell the healthcare team about reactions to medicines, injections, or biologic treatments.
  • Attend monitoring appointments: Complete any recommended examinations or blood tests.
  • Discuss vaccinations: Ask whether any vaccines should be considered before or during treatment.
  • Report new symptoms: Inform the prescribing team about unusual or persistent changes after treatment.
  • Continue other asthma medicines: Do not stop inhalers or oral corticosteroids on your own when starting a biologic.

Biologics are generally added to existing asthma treatment rather than replacing all other medicines. Any reduction in corticosteroid treatment should be planned and supervised by the healthcare professional managing the asthma.

Do the benefits of asthma biologics outweigh their side effects?

For appropriately selected people with severe asthma, biologics may reduce asthma attacks, improve symptom control, and reduce the need for oral corticosteroids. These potential benefits need to be weighed against the possible side effects of the specific medicine.

The Asthma + Lung UK guide to biologic therapies explains that biologics are additional treatments and that patients should continue their usual asthma medicines unless their specialist advises otherwise.

The decision to start or continue treatment depends on factors such as asthma severity, previous attacks, the type of inflammation involved, response to treatment, and individual safety concerns.

If a side effect develops, the prescribing team can assess whether it is related to the medicine and whether monitoring, symptom management, or a change in treatment is appropriate. Patients should not discontinue a biologic or change their other asthma medicines without medical guidance.

Frequently Asked Questions

Answers to common questions about the safety and possible side effects of biologic treatments for asthma.

Are asthma biologics safer than steroid tablets?

Biologics target specific immune pathways, while corticosteroids have broader anti-inflammatory effects. Biologics may help some people reduce their need for long-term oral steroids. However, they have their own risks, including injection reactions and allergic reactions. Neither treatment is automatically safer for everyone.

Can asthma biologics cause weight gain?

Weight gain is not a common listed side effect shared by asthma biologics. However, people taking long-term oral corticosteroids may experience weight changes related to those medicines. Discuss unexplained weight changes with your healthcare professional.

How long do side effects from asthma biologics last?

The duration depends on the medicine and the type of reaction. Mild injection-site discomfort may settle within a few days. Other reactions may last longer or require medical assessment. Serious allergic reactions need immediate emergency treatment.

Can you stop asthma biologics if you experience side effects?

Do not stop or change treatment without discussing it with your prescribing specialist. They can assess the reaction and decide whether continued treatment, additional monitoring, or a different biologic is appropriate. Suspected anaphylaxis requires emergency medical attention.

Do asthma biologics weaken the immune system?

Asthma biologics target specific immune signals or cells involved in inflammation rather than suppressing the entire immune system in the same way as some other medicines. Infection-related risks vary between treatments, so patients should discuss their individual infection history and vaccination needs with their healthcare professional.

Citations

  1. American Academy of Allergy, Asthma and Immunology – Biologics for the Management of Severe Asthma
  2. DailyMed – Xolair (Omalizumab) Prescribing Information
  3. DailyMed – Fasenra (Benralizumab) Prescribing Information
  4. Sitek A, Chiarella SE, Pongdee T. Adverse Effects of Biologics Used to Treat Asthma. 2025.
  5. Asthma + Lung UK – Biologic Therapies: Risks and Side Effects
Share this article